AI Article Synopsis

  • Seizures from organophosphorus nerve agents resist benzodiazepine treatment due to rapid internalization of synaptic GABA receptors, while extrasynaptic receptors remain available and are targeted for better management of these seizures.
  • Neurosteroids, like allopregnanolone, show promise as alternatives because they activate both synaptic and extrasynaptic GABA receptors, offering longer-lasting effectiveness and protection against neuronal death, though their use is hampered by formulation challenges.
  • A non-steroidal enaminone called 2-261 effectively terminated seizures for over 10 hours in animal models and reduced neuronal damage, though it acted slowly as a standalone treatment but enhanced the effectiveness of benzodiazepines.

Article Abstract

Seizures induced by organophosphorus nerve agent exposure become refractory to treatment with benzodiazepines because these drugs engage synaptic γ-aminobutyric acid-A receptors (GABARs) that rapidly internalize during (SE). Extrasynaptic GABARs, such as those containing αβδ subunits, are a putative pharmacological target to comprehensively manage nerve agent-induced seizures since they do not internalize during SE and are continuously available for activation. Neurosteroids related to allopregnanolone have been tested as a possible replacement for benzodiazepines because they target both synaptic and extrasynaptic GABARs receptors. A longer effective treatment window, extended treatment efficacy, and enhanced neuroprotection represent significant advantages of neurosteroids over benzodiazepines. However, neurosteroid use is limited by poor physicochemical properties arising from the intrinsic requirement of the pregnane steroid core structure for efficacy rendering drug formulation problematic. We tested a non-steroidal enaminone GABAR modulator that interacts with both synaptic and extrasynaptic GABARs on a binding site distinct from neurosteroids or benzodiazepines for efficacy to control electrographic SE induced by diisopropyl fluorophosphate or soman intoxication in rats. Animals were treated with standard antidotes, and experimental therapeutic treatment was given following 1 h (diisopropyl fluorophosphate model) or 20 min (soman model) after SE onset. We found that the enaminone 2-261 had an extended duration of seizure termination (>10 h) in the diisopropyl fluorophosphate intoxication model in the presence or absence of midazolam (MDZ). 2-261 also moderately potentiated MDZ in the soman-induced seizure model but had limited efficacy as a stand-alone anticonvulsant treatment due to slow onset of action. 2-261 significantly reduced neuronal death in brain areas associated with either diisopropyl fluorophosphate- or soman-induced SE. 2-261 represents an alternate chemical template from neurosteroids for enhancing extrasynaptic αβδ GABAR activity to reverse SE from organophosphorous intoxication.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543275PMC
http://dx.doi.org/10.3389/fphar.2019.00560DOI Listing

Publication Analysis

Top Keywords

extrasynaptic gabars
12
diisopropyl fluorophosphate
12
extrasynaptic αβδ
8
synaptic extrasynaptic
8
neurosteroids benzodiazepines
8
extrasynaptic
5
treatment
5
enaminone modulators
4
modulators extrasynaptic
4
αβδ γ-aminobutyric
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!